The Week in Review: January 26 – February 2, 2018

Friday, February 2, 2018 News Recap: From the Uh-Oh Department: HCV Can Reactivate with Treatment of Non-hepatic Cancer. Hepatitis C virus (HCV) reactivation occurred in approximately 1 out of 5 patients treated for non-hepatic cancer, posing renewed risk for hepatic injury and possibly complicating the cancer treatment. Compensation Update: Compensation – New Update for 86-90 Late Claims. If you or a family member received a blood transfusion o...

SVR for HCV with no advanced liver disease greatly reduces mortality risk

Patients with hepatitis C without advanced liver disease who achieved sustained virologic response with direct-acting antiviral therapy had significantly reduced all-cause mortality rates compared with both treated patients who did not achieve SVR and untreated patients, according to a recently published data. “These data strongly support a clinically significant benefit of DAA treatment in patients without clinically apparent advanced liver disease and e

The Week in Review: October 13 – October 20, 2017

Friday, October 20, 2017 News Recap: Disease Management: Women: Hepatitis C in pregnancy: screening, treatment, and management. Hepatitis C (HCV) during pregnancy is associated with serious, adverse outcomes. Infants born to women with HCV are more likely to experience fetal growth restriction and low birth weight. For women, chronic HCV is associated with progressive liver damage and, during pregnancy, can be transmitted from the mother to the fe...

SVR reduces hepatic venous pressure gradient, portal hypertension persists

Sustained virologic response correlated with reduced hepatic venous pressure gradient in patients with HCV-associated cirrhosis, according to a recently published study. However, clinically significant portal hypertension continued to persist in most patients. “Development of [clinically significant portal hypertension] is a hallmark in the natural history of cirrhosis because it is associated with a higher risk of hepatic decompensation, and increased ri

Hepatitis C Still Increases Mortality Rate After Being Cured

“Patients cured of hepatitis C through treatment had a higher mortality rate overall than the general population,” the team concluded. “The excess was driven by death from drug-related causes and liver cancer.” The good news is that many hepatitis C treatments have at least a 90% cure rate. But the bad news is that people who had hepatitis C still have higher mortality rates than the general population. Despite being curable, hepatitis C kills more peo


Hepatitis C. . . NOT JUST A LIVER DISEASE: “Hepatitis” means an inflammation of the liver. Hepatitis C affects many other parts of the body as well as the liver. A SILENT KILLER: There are many kinds of hepatitis virus including hepatitis A, B, C, D, and so on. Hepatitis C is only one kind, but it kills the most people, worldwide. Many people don’t know they have it until after terrible damage has been done. COMES FROM: Hepatitis can be caused by